Table of Contents :
• Stock Rating & Target Price
• Investment Thesis
• Fundamental Models Used
• Company Description
• Corporate Timeline
• Key Metrics (KPI ) and Recently Reported Earnings Review
• Business Highlights, Strategic Announcements & Outlook
• Quarter-over-Quarter (Q-o-Q) and Year-over-Year (Y-o-Y) Growth Analysis
• Key Catalysts Driving Growth
• Historical Financial Statement Analysis & CAGR Trends
• Quarterly Key Financial Ratios and Performance Metrics
• Annual Financial Performance Analysis: Horizontal and Vertical Financial Analysis, Trends
• Financial Forecasts
• Annual Forecasts: Income Statement
• Annual Forecasts: Cash Flow Statements
• Net Debt Levels
• A Closer Look at DCF: Our Assumptions and Methodology
• Terminal Value Calculation
• Target Price Analysis
• Valuation Multiples
• Supplementary Valuation Analysis: Multiples Approach
• Scenario/Sensitivity Analysis – Base Case , Bull Case ,Bear Case
• Holistic Peer Review & Trading Comps: Financial Data, Operational Metrics, and Valuation Multiples
• Implied Price Per Share
• Ownership Activity/ Insider Trades
• Ownership Summary
• An analysis of ESG Risk Rating
• Key Professionals
• Key Board Members
• Key Risks Considerations
• Analyst Ratings
• Analyst Industry Views
• Disclosures
Dow Inc. (DOW): Discounted Deeply—Margin Pain, Tariff Strain, But a Snapback Could Make This High-Leverage Commodity Pure-Play Roar!
Dow’s Q1FY25 results reflect disciplined navigation through a prolonged downcycle, with ongoing EPS of $0.60 driven by its sixth straight quarter of volume growth despite 3% YoY sales decline and compressed margins. Segment performance was mixed: Packaging & Specialty Plastics (P&SP) saw margin headwinds despite +4% volume growth; Industrial Intermediates & Infrastructure (II&I) was weighed down by weak durable demand; while Performance Materials & Coatings showed strength in downstream silicones for electronics and personal care, now a stabilizing profit lever. Dow's $6B in near-term cash levers—Macquarie proceeds, Nova litigation award, and CapEx cuts—alongside $1B in cost savings by 2026 and a prudent Path2Zero pause, reflect a necessary pivot to conserve cash and defend its dividend amid negative free cash flow in 2024. European asset rationalization continues as demand remains structurally weak. Q2 EBITDA is guided flat QoQ (~$944M), with coatings seasonality and silicones momentum offsetting headwinds in polyethylene and MEG. Tailwinds include >95% USMCA-compliant feedstock positioning, emerging AI/pharma-linked silicone demand, and added downstream capacity in H2. Still, tariff uncertainty, macro softness, and high operating leverage widen the risk envelope. Can Dow leverage its volume momentum, cost resets, and cash unlocks to defend margins and dividends until a true margin-cycle snapback emerges?
